Northern Trust Corp Fennec Pharmaceuticals Inc. Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 138,375 shares of FENC stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,375
Previous 136,755 1.18%
Holding current value
$1.14 Million
Previous $864,000 2.55%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$5.54 - $7.02 $8,974 - $11,372
1,620 Added 1.18%
138,375 $842,000
Q4 2024

Feb 14, 2025
SELL
$3.99 - $6.37 $11,874 - $18,957
-2,976 Reduced 2.13%
136,755 $864,000
Q3 2024

Nov 13, 2024
BUY
$4.85 - $6.73 $161,660 - $224,324
33,332 Added 31.33%
139,731 $698,000
Q2 2024

Aug 14, 2024
SELL
$6.02 - $10.99 $46,167 - $84,282
-7,669 Reduced 6.72%
106,399 $650,000
Q1 2024

May 14, 2024
BUY
$8.82 - $11.12 $20,356 - $25,664
2,308 Added 2.07%
114,068 $1.27 Million
Q4 2023

Feb 13, 2024
BUY
$6.48 - $11.61 $5,812 - $10,414
897 Added 0.81%
111,760 $1.25 Million
Q3 2023

Nov 13, 2023
SELL
$7.15 - $8.94 $25,883 - $32,362
-3,620 Reduced 3.16%
110,863 $832,000
Q2 2023

Aug 11, 2023
BUY
$7.27 - $9.82 $832,291 - $1.12 Million
114,483 New
114,483 $1.01 Million
Q2 2021

Aug 13, 2021
SELL
$5.96 - $7.85 $1.09 Million - $1.43 Million
-182,107 Closed
0 $0
Q1 2021

May 12, 2021
SELL
$6.21 - $8.68 $135,949 - $190,022
-21,892 Reduced 10.73%
182,107 $1.13 Million
Q4 2020

Feb 11, 2021
SELL
$5.99 - $8.55 $15,783 - $22,529
-2,635 Reduced 1.28%
203,999 $1.52 Million
Q3 2020

Nov 16, 2020
SELL
$5.19 - $10.17 $53,072 - $103,998
-10,226 Reduced 4.72%
206,634 $1.25 Million
Q2 2020

Aug 14, 2020
BUY
$5.43 - $9.39 $1.18 Million - $2.04 Million
216,860 New
216,860 $1.81 Million
Q3 2019

Nov 13, 2019
SELL
$3.85 - $4.95 $373,342 - $480,011
-96,972 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$3.3 - $5.09 $16,846 - $25,984
-5,105 Reduced 5.0%
96,972 $388,000
Q1 2019

May 13, 2019
BUY
$4.64 - $7.58 $1,020 - $1,667
220 Added 0.22%
102,077 $495,000
Q4 2018

Feb 12, 2019
SELL
$5.37 - $8.39 $1,224 - $1,912
-228 Reduced 0.22%
101,857 $650,000
Q3 2018

Nov 14, 2018
BUY
$7.84 - $10.83 $5,903 - $8,154
753 Added 0.74%
102,085 $837,000
Q2 2018

Aug 14, 2018
BUY
$10.05 - $14.33 $1.02 Million - $1.45 Million
101,332 New
101,332 $1.06 Million

Others Institutions Holding FENC

# of Institutions
70
Shares Held
13.9M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $215M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email